| 000 | 01904 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516115229.0 | ||
| 264 | 0 | _c20140109 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1791-2431 | ||
| 024 | 7 |
_a10.3892/or.2012.2085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXiao, Huijie | |
| 245 | 0 | 0 |
_aSeparate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells. _h[electronic resource] |
| 260 |
_bOncology reports _cJan 2013 |
||
| 300 |
_a329-34 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aAntimetabolites _xpharmacology |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCell Hypoxia _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aDeoxyglucose _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFumarates _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aPyruvate Dehydrogenase Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyruvates _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aLi, Shasha | |
| 700 | 1 | _aZhang, Dapeng | |
| 700 | 1 | _aLiu, Tongjun | |
| 700 | 1 | _aYu, Ming | |
| 700 | 1 | _aWang, Feng | |
| 773 | 0 |
_tOncology reports _gvol. 29 _gno. 1 _gp. 329-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2012.2085 _zAvailable from publisher's website |
| 999 |
_c22193242 _d22193242 |
||